These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 34381593)

  • 1. Case Report: Pseudomonas can take a toll on a patient.
    Buchbinder DK; Singh J; Dao T; Sassoon A; Arrieta A
    F1000Res; 2021; 10():526. PubMed ID: 34381593
    [No Abstract]   [Full Text] [Related]  

  • 2. Human airway epithelial cells sense Pseudomonas aeruginosa infection via recognition of flagellin by Toll-like receptor 5.
    Zhang Z; Louboutin JP; Weiner DJ; Goldberg JB; Wilson JM
    Infect Immun; 2005 Nov; 73(11):7151-60. PubMed ID: 16239509
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Toll-like receptors in the host defense against Pseudomonas aeruginosa respiratory infection and cystic fibrosis.
    McIsaac SM; Stadnyk AW; Lin TJ
    J Leukoc Biol; 2012 Nov; 92(5):977-85. PubMed ID: 22892106
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical features and outcome of patients with IRAK-4 and MyD88 deficiency.
    Picard C; von Bernuth H; Ghandil P; Chrabieh M; Levy O; Arkwright PD; McDonald D; Geha RS; Takada H; Krause JC; Creech CB; Ku CL; Ehl S; Maródi L; Al-Muhsen S; Al-Hajjar S; Al-Ghonaium A; Day-Good NK; Holland SM; Gallin JI; Chapel H; Speert DP; Rodriguez-Gallego C; Colino E; Garty BZ; Roifman C; Hara T; Yoshikawa H; Nonoyama S; Domachowske J; Issekutz AC; Tang M; Smart J; Zitnik SE; Hoarau C; Kumararatne DS; Thrasher AJ; Davies EG; Bethune C; Sirvent N; de Ricaud D; Camcioglu Y; Vasconcelos J; Guedes M; Vitor AB; Rodrigo C; Almazán F; Méndez M; Aróstegui JI; Alsina L; Fortuny C; Reichenbach J; Verbsky JW; Bossuyt X; Doffinger R; Abel L; Puel A; Casanova JL
    Medicine (Baltimore); 2010 Nov; 89(6):403-425. PubMed ID: 21057262
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immune surveillance mechanisms of the skin against the stealth infection strategy of Pseudomonas aeruginosa-review.
    Andonova M; Urumova V
    Comp Immunol Microbiol Infect Dis; 2013 Sep; 36(5):433-48. PubMed ID: 23602428
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of Toll interleukin-1 receptor (IL-1R) 8, a negative regulator of IL-1R/Toll-like receptor signaling, in resistance to acute Pseudomonas aeruginosa lung infection.
    Véliz Rodriguez T; Moalli F; Polentarutti N; Paroni M; Bonavita E; Anselmo A; Nebuloni M; Mantero S; Jaillon S; Bragonzi A; Mantovani A; Riva F; Garlanda C
    Infect Immun; 2012 Jan; 80(1):100-9. PubMed ID: 22025515
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interleukin receptor-associated kinase-4 deficiency impairs Toll-like receptor-dependent innate antiviral immune responses.
    McDonald DR; Brown D; Bonilla FA; Geha RS
    J Allergy Clin Immunol; 2006 Dec; 118(6):1357-62. PubMed ID: 17157666
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Chinese expert consensus on the management of lower respiratory tract infections of
    Pulmonary Infection Assembly of Chinese Thoracic Society
    Zhonghua Jie He He Hu Xi Za Zhi; 2022 Aug; 45(8):739-752. PubMed ID: 35927044
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Redundant Toll-like receptor signaling in the pulmonary host response to Pseudomonas aeruginosa.
    Skerrett SJ; Wilson CB; Liggitt HD; Hajjar AM
    Am J Physiol Lung Cell Mol Physiol; 2007 Jan; 292(1):L312-22. PubMed ID: 16936244
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A novel mouse model of conditional IRAK-M deficiency in myeloid cells: application in lung Pseudomonas aeruginosa infection.
    Jiang D; Matsuda J; Berman R; Schaefer N; Stevenson C; Gross J; Zhang B; Sanchez A; Li L; Chu HW
    Innate Immun; 2017 Feb; 23(2):206-215. PubMed ID: 28120642
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Deficiency of interleukin-1 receptor-associated kinase 4 presenting as fatal Pseudomonas aeruginosa bacteremia in two siblings.
    Stergiopoulou T; Walsh TJ; Seghaye MC; Netea MG; Casanova JL; Moutschen M; Picard C
    Pediatr Infect Dis J; 2015 Mar; 34(3):299-300. PubMed ID: 25232776
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interleukin 7 immunotherapy improves host immunity and survival in a two-hit model of Pseudomonas aeruginosa pneumonia.
    Shindo Y; Fuchs AG; Davis CG; Eitas T; Unsinger J; Burnham CD; Green JM; Morre M; Bochicchio GV; Hotchkiss RS
    J Leukoc Biol; 2017 Feb; 101(2):543-554. PubMed ID: 27630218
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Toll-like receptor 2 deficiency increases resistance to Pseudomonas aeruginosa pneumonia in the setting of sepsis-induced immune dysfunction.
    Pène F; Grimaldi D; Zuber B; Sauneuf B; Rousseau C; El Hachem C; Martin C; Belaïdouni N; Balloy V; Mira JP; Chiche JD
    J Infect Dis; 2012 Sep; 206(6):932-42. PubMed ID: 22782952
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pseudomonas aeruginosa Stimulates Inflammation and Enhances Kaposi's Sarcoma Herpesvirus-Induced Cell Proliferation and Cellular Transformation through both Lipopolysaccharide and Flagellin.
    Markazi A; Bracci PM; McGrath M; Gao SJ
    mBio; 2020 Nov; 11(6):. PubMed ID: 33173008
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Flagellin induces myeloid-derived suppressor cells: implications for Pseudomonas aeruginosa infection in cystic fibrosis lung disease.
    Rieber N; Brand A; Hector A; Graepler-Mainka U; Ost M; Schäfer I; Wecker I; Neri D; Wirth A; Mays L; Zundel S; Fuchs J; Handgretinger R; Stern M; Hogardt M; Döring G; Riethmüller J; Kormann M; Hartl D
    J Immunol; 2013 Feb; 190(3):1276-84. PubMed ID: 23277486
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Two novel compound heterozygous loss-of-function mutations cause fetal IRAK-4 deficiency presenting with Pseudomonas Aeruginosa sepsis.
    Zhang F; Wang Z; Men S; Zhang J; Wang L
    Clin Immunol; 2024 Aug; 265():110268. PubMed ID: 38838930
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Resistance to Pseudomonas aeruginosa chronic lung infection requires cystic fibrosis transmembrane conductance regulator-modulated interleukin-1 (IL-1) release and signaling through the IL-1 receptor.
    Reiniger N; Lee MM; Coleman FT; Ray C; Golan DE; Pier GB
    Infect Immun; 2007 Apr; 75(4):1598-608. PubMed ID: 17283089
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pseudomonas aeruginosa Regulatory Protein AnvM Controls Pathogenicity in Anaerobic Environments and Impacts Host Defense.
    Zhang Y; Zhou CM; Pu Q; Wu Q; Tan S; Shao X; Zhang W; Xie Y; Li R; Yu XJ; Wang R; Zhang L; Wu M; Deng X
    mBio; 2019 Jul; 10(4):. PubMed ID: 31337721
    [No Abstract]   [Full Text] [Related]  

  • 19. Interleukin-36γ and IL-36 receptor signaling mediate impaired host immunity and lung injury in cytotoxic Pseudomonas aeruginosa pulmonary infection: Role of prostaglandin E2.
    Aoyagi T; Newstead MW; Zeng X; Nanjo Y; Peters-Golden M; Kaku M; Standiford TJ
    PLoS Pathog; 2017 Nov; 13(11):e1006737. PubMed ID: 29166668
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pseudomonas aeruginosa infection and inflammation during contact lens wear: a review.
    Willcox MD
    Optom Vis Sci; 2007 Apr; 84(4):273-8. PubMed ID: 17435510
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.